Research Operations
How Sites Can Win in the New Age of Genetically Engineered Treatments
The accelerating gene therapy market is expected to grow 16.6 percent by 2027. As gene therapies enter the pipeline, how can sites prepare themselves to take advantage of the rush?
How Staff Augmentation Assists with Successful Data Migration
With the goal to move active data from one system into OnCore CTMS, Advarra’s Staff Augmentation team worked with a customer’s associated hospital as it was faced with software termination.
UChicago Comprehensive Cancer Center Adopts Industry-Leading Research Administration Technology
Biosafety, Ethical, and Logistical Challenges to Pursuing a Coronavirus Vaccine at Warp Speed
The SARS-CoV-2 pandemic has impacted all aspects of society. Various government and private groups around the world are endeavoring to develop safe and effective vaccines at an unprecedented pace and scale to quell the pandemic as quickly as possible.
Wayne State University Streamlines Compliance with Validation Services for Advarra EDC
Understanding the Complexity and Uniqueness of Phase I Trials
There are many distinctions that set Phase I trials apart from the rest. For sites aiming for a successful Phase I trial, working with an organization that understands the nuances is key.
Utilizing eRegulatory Integrations to Expedite Regulatory Workflows
Learn how key eRegulatory integrations like email, local and central IRBs, and Clinical Trial Management Systems can accelerate study start up, increase compliance, and improve regulatory workflows.
Inova Health System Uses Advarra eReg Workflows and Integrations to Improve Regulatory Efficiency
Expanding Our Global Consulting Expertise to Solve Mission-Critical Issues
Elevating our consulting capabilities to accelerate clinical research and bring therapies to market sooner.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2025 Advarra. All Rights Reserved.